Knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers - a cross-sectional study.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Anti-Bacterial Agents
/ therapeutic use
Cities
Cross-Sectional Studies
Drug Resistance, Microbial
Educational Status
Female
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Norway
Pharmacies
Sex Factors
Surveys and Questionnaires
Virus Diseases
/ drug therapy
Young Adult
Antibiotic knowledge
Antibiotic resistance
Antibiotics
Attitudes
BMQ
Beliefs about medicines
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
15 Jan 2019
15 Jan 2019
Historique:
received:
16
04
2018
accepted:
07
01
2019
entrez:
17
1
2019
pubmed:
17
1
2019
medline:
20
2
2019
Statut:
epublish
Résumé
Antibiotic resistance is a global health threat. Public knowledge is considered a prerequisite for appropriate use of antibiotics and limited spread of antibiotic resistance. Our aim was to examine the level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, and to assess to which degree beliefs, attitudes and sociodemographic factors are associated with this knowledge. A questionnaire based, cross-sectional study was conducted among pharmacy customers in three Norwegian cities. The questionnaire covered 1) knowledge of antibiotics (13 statements) and antibiotic resistance (10 statements), 2) the general beliefs about medicines questionnaire (BMQ general) (three subdomains, four statements each), 3) attitudes toward antibiotic use (four statements), and 4) sociodemographic factors, life style and health. High knowledge level was defined as > 66% of maximum score. Factors associated with knowledge of antibiotics and antibiotic resistance were investigated through univariate and multiple linear regression. Hierarchical model regression was used to estimate a population average knowledge score weighted for age, gender and level of education. Among 877 participants, 57% had high knowledge of antibiotics in general and 71% had high knowledge of antibiotic resistance. More than 90% knew that bacteria can become resistant against antibiotics and that unnecessary use of antibiotics can make them less effective. Simultaneously, more than 30% erroneously stated that antibiotics are effective against viruses, colds or influenza. Factors positively associated with antibiotic knowledge were health professional background, high education level, and a positive view on the value of medications in general. Male gender, a less restrictive attitude toward antibiotic use, and young age were negatively associated with antibiotic knowledge. The mean overall antibiotic knowledge score was relatively high (15.6 out of maximum 23 with estimated weighted population score at 14.8). Despite a high level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, there are obvious knowledge gaps. We suggest that action is taken to increase the knowledge level, and particularly target people in vocational, male dominated occupations outside the health service, and primary/secondary school curricula.
Sections du résumé
BACKGROUND
BACKGROUND
Antibiotic resistance is a global health threat. Public knowledge is considered a prerequisite for appropriate use of antibiotics and limited spread of antibiotic resistance. Our aim was to examine the level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, and to assess to which degree beliefs, attitudes and sociodemographic factors are associated with this knowledge.
METHODS
METHODS
A questionnaire based, cross-sectional study was conducted among pharmacy customers in three Norwegian cities. The questionnaire covered 1) knowledge of antibiotics (13 statements) and antibiotic resistance (10 statements), 2) the general beliefs about medicines questionnaire (BMQ general) (three subdomains, four statements each), 3) attitudes toward antibiotic use (four statements), and 4) sociodemographic factors, life style and health. High knowledge level was defined as > 66% of maximum score. Factors associated with knowledge of antibiotics and antibiotic resistance were investigated through univariate and multiple linear regression. Hierarchical model regression was used to estimate a population average knowledge score weighted for age, gender and level of education.
RESULTS
RESULTS
Among 877 participants, 57% had high knowledge of antibiotics in general and 71% had high knowledge of antibiotic resistance. More than 90% knew that bacteria can become resistant against antibiotics and that unnecessary use of antibiotics can make them less effective. Simultaneously, more than 30% erroneously stated that antibiotics are effective against viruses, colds or influenza. Factors positively associated with antibiotic knowledge were health professional background, high education level, and a positive view on the value of medications in general. Male gender, a less restrictive attitude toward antibiotic use, and young age were negatively associated with antibiotic knowledge. The mean overall antibiotic knowledge score was relatively high (15.6 out of maximum 23 with estimated weighted population score at 14.8).
CONCLUSIONS
CONCLUSIONS
Despite a high level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, there are obvious knowledge gaps. We suggest that action is taken to increase the knowledge level, and particularly target people in vocational, male dominated occupations outside the health service, and primary/secondary school curricula.
Identifiants
pubmed: 30646892
doi: 10.1186/s12889-019-6409-x
pii: 10.1186/s12889-019-6409-x
pmc: PMC6332570
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
66Références
Acta Psychiatr Scand. 2009 Jan;119(1):78-84
pubmed: 18983630
J Med Internet Res. 2015 Aug 13;17(8):e193
pubmed: 26272267
Pharm World Sci. 2010 Feb;32(1):97-102
pubmed: 19921545
Tidsskr Nor Laegeforen. 2009 Dec 17;129(24):2610-2
pubmed: 20029557
PLoS One. 2016 Apr 20;11(4):e0152160
pubmed: 27096751
Tidsskr Nor Laegeforen. 2011 Apr 8;131(7):680-3
pubmed: 21494302
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3035-3039
pubmed: 28265082
Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1234-43
pubmed: 17879325
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
J Antimicrob Chemother. 2007 May;59(5):971-6
pubmed: 17329270
PLoS One. 2013 Dec 23;8(12):e84177
pubmed: 24376793
J Antimicrob Chemother. 2010 Jun;65(6):1292-6
pubmed: 20360063
Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):2-10
pubmed: 25251203
J Am Board Fam Med. 2010 Mar-Apr;23(2):159-65
pubmed: 20207925
J Antimicrob Chemother. 2016 Jan;71(1):27-33
pubmed: 26459555
J Antimicrob Chemother. 2017 Apr 1;72(4):975-987
pubmed: 27999058
Patient Educ Couns. 2018 Apr;101(4):679-686
pubmed: 29249596